IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 166 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,634 | +8.9% | 13,773 | +20.3% | 0.01% | 0.0% |
| Q2 2023 | $121,796 | +12.9% | 11,447 | +11.7% | 0.01% | +25.0% |
| Q1 2023 | $107,841 | -7.6% | 10,251 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $116,759 | +10.2% | 10,251 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $106,000 | -10.2% | 10,251 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $118,000 | -17.5% | 10,251 | -10.0% | 0.01% | 0.0% |
| Q1 2022 | $143,000 | +7.5% | 11,391 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $133,000 | -10.7% | 11,391 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $149,000 | +1.4% | 11,391 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $147,000 | +1.4% | 11,391 | -12.2% | 0.01% | -16.7% |
| Q1 2021 | $145,000 | -7.6% | 12,980 | -6.0% | 0.01% | -14.3% |
| Q4 2020 | $157,000 | +26.6% | 13,813 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $124,000 | -13.3% | 13,813 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $143,000 | +2.9% | 13,813 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $139,000 | -20.1% | 13,813 | +5.6% | 0.01% | 0.0% |
| Q4 2019 | $174,000 | +55.4% | 13,086 | 0.0% | 0.01% | +60.0% |
| Q3 2019 | $112,000 | -21.7% | 13,086 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $143,000 | -10.6% | 13,086 | +10.7% | 0.01% | 0.0% |
| Q1 2019 | $160,000 | +31.1% | 11,821 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $122,000 | -44.0% | 11,821 | 0.0% | 0.01% | -30.0% |
| Q3 2018 | $218,000 | -3.5% | 11,821 | 0.0% | 0.01% | -9.1% |
| Q2 2018 | $226,000 | +24.2% | 11,821 | 0.0% | 0.01% | +22.2% |
| Q1 2018 | $182,000 | +2.8% | 11,821 | 0.0% | 0.01% | +12.5% |
| Q4 2017 | $177,000 | -5.9% | 11,821 | 0.0% | 0.01% | -11.1% |
| Q3 2017 | $188,000 | -15.7% | 11,821 | 0.0% | 0.01% | -18.2% |
| Q2 2017 | $223,000 | +16.8% | 11,821 | +5.8% | 0.01% | +22.2% |
| Q1 2017 | $191,000 | +11.7% | 11,173 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $171,000 | -3.4% | 11,173 | 0.0% | 0.01% | -10.0% |
| Q3 2016 | $177,000 | +3.5% | 11,173 | +4.3% | 0.01% | -9.1% |
| Q1 2015 | $171,000 | +4.3% | 10,708 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $164,000 | +18.0% | 10,708 | 0.0% | 0.01% | +10.0% |
| Q3 2014 | $139,000 | -15.2% | 10,708 | 0.0% | 0.01% | -16.7% |
| Q2 2014 | $164,000 | – | 10,708 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |